**REGISTERED COMPANY NUMBER: 07476120 (England and Wales) REGISTERED CHARITY NUMBER: 1142803** Report of the Trustees and Unaudited Financial Statements for the Year Ended 31 December 2022 for Global Sepsis Alliance Avalon Accounting Limited 12 Park Lane Tilehurst Reading Berkshire RG31 5DL Global Sepsis Alliance ## Contents of the Financial Statements for the Year Ended 31 December 2022 |||Page|| |---|---|---|---| |Report of the Trustees|1|to|6| |Independent Examiner's Report||7|| |Statement of Financial Activities||8|| |Balance Sheet|9|to|10| |Notes to the Financial Statements|11|to|16| |Detailed Statement of Financial Activities|17|to|18| Global Sepsis Alliance ## Report of the Trustees for the Year Ended 31 December 2022 The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2022. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). Page 1 Global Sepsis Alliance ## Report of the Trustees for the Year Ended 31 December 2022 ## **OBJECTIVES AND ACTIVITIES** ## **Objectives and aims** Our charity's purposes as set out in the objects contained in the company's Memorandum of Association are for the public benefit to relieve sickness and promote and protect the physical and mental health of persons suffering from sepsis by: - the provision of financial assistance, support, education, research and practical advice; and - increasing awareness and understanding of sepsis and its treatment amongst health professionals, corporation governmental and non-governmental organizations, and the public. The aims of our charity are to raise awareness and understanding of sepsis and its treatment and educate a range of audiences, both professional and lay public. Our aims fully reflect the purposes that the charity was set up to further. ## **Ensuring our work delivers our aims** The charity continues to be in its formative years, but we review our aims, objectives, and activities each year. This review outlines what we achieved and the outcomes of our work in the previous 12 months. The review also identifies where each key activity has been successful and the benefits they have brought to those groups of people we were established to help. The review also helps us ensure our aim, objectives, and activities remained focused on our stated purposes. We have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing our aim and objectives and in planning our future activities. In particular, the Trustees and Executive Committee jointly consider how planned activities will contribute to the aims and objectives they have set. ## **The focus of our work** Our main objectives for the year 2022 continued to be those activities aimed at raising awareness and understanding of sepsis and its treatment, as well as igniting necessary policy changes and mental shifts in policymakers and governmental institutions, especially those involved in policymaking. These objectives are how we will actively pursue our vision: **A WORLD FREE OF SEPSIS** The strategies we used to meet these objectives included: - working closely with the WHO and national governments towards having the World Health Assembly (WHA) adopt a resolution on sepsis. This was achieved in May 2017 at the 70th WHA, marking a quantum leap in the global fight against sepsis which was spearheaded by the GSA; - working closely with the WHO and national governments to implement the demands of said WHA Resolution on Sepsis; especially fostering national sepsis strategies, and the integration of sepsis in existing health strategies - the instigation of the first World Sepsis Day in September 2012 which is now a recurring annual event involving more than 60 countries and more than 300 events - working to get World Sepsis Day officially recognized as a World Health Day by the World Health Organization - the instigation of the Global Sepsis Awards in 2015, which is now a recurring initiative to highlight sepsis related projects and - achievements on a global level each year - the establishment of World Sepsis Congress in 2016 and World Sepsis Congress Spotlight in 2017. These free online conferences make knowledge about sepsis accessible to all parts of the world - In 2022, we hosted the 2022 WSC Spotlight, titled 'WSC Spotlight: Novel Therapeutic and Diagnostic Approaches for COVID-19 and Sepsis' in April of 2022. The 2022 WSC Spotlight had more than 10,000 registrations from more than 180 countries, 8 sessions, and more than 45 speakers, moderators, and panelists. All talks are available for free on YouTube and as a podcast. - the development and continuous maintenance and updating of websites for World Sepsis Day (www.worldsepsisday.org), World Sepsis Congress (www.worldsepsiscongress.org), WSC Spotlight (www.wscspotlight.org), as well as the Global Sepsis Alliance (http://www.globalsepsisalliance.org/) - the development and publication of the World Sepsis Declaration, which was recently updated with goals and targets for 2030 and - serves as our North Star - the development and publication of relevant and timely news posts on our WSD and GSA websites, an email newsletter, as well as the use of social media, especially Twitter, Instagram, and Facebook - sharing stories of people impacted by sepsis on our website and on social media; - growing the network of the GSA (over 110 members at the end of 2022) - working towards applying international standards and guidelines, in close connection to the demands of the before-mentioned - resolution - working in partnership with other organizations and agencies to secure the widest range of initiatives and encouraging action on sepsis. Page 2 ## Global Sepsis Alliance ## Report of the Trustees ## for the Year Ended 31 December 2022 Briefly mentioned above, of specific significance in 2022 was the '2022 World Sepsis Congress Spotlight' - over the course of one days and 8 diverse and highly relevant sessions, over 45 speakers, panelists, and moderators from more than 30 countries gave trenchant talks on all the newest therapeutic and diagnostic approaches for COVID-19 and sepsis, covering all novel aspects of our understanding of bacterial and viral sepsis, from new methods of diagnosis and risk assessment to novel treatment modalities, and beyond. The congress took place entirely online and participation was free of charge, allowing participants to join from wherever they had an internet connection. The congress was a sweeping success, with more than 10,000 registrations from more than 180 countries. 65% of our audience joined from low- and middle-income countries (LMIC) - the majority of whom could not have afforded to travel to a physical congress to learn about sepsis. All presentations were recorded and continue to be available on our YouTube channel and on Apple Podcasts, easily accessible and free of charge. We plan to host the 4th World Sepsis Congress in 2023, and the 2024 WSC Spotlight in 2024. Thanks to COVID, the GSA Awards were presented in a virtual ceremony this year. Throughout the year, the GSA also supported and promoted other health days with a relationship to sepsis, such as World Hand Hygiene Day and World Patient Safety Day. In early 2022, the GSA supported the IMC White Paper, which proposes a holistic infection management roadmap integrating AMR and sepsis. The GSA also kept on supporting and growing its regional sepsis alliances - including their events, such as webinars and physical meetings. September also saw a big celebratory #10YearsWSD-Event in Berlin, as well as the 5th Annual Meeting of the European Sepsis Alliance in Brussels, featuring Stella Kyriakides, the European Commissioner for Health and Food Safety. Gearing up for World Sepsis Day, we launched a new interactive world map, as well as a new interactive virtual photo booth - a super fun and engaging way to participate in WSD online. Over the year, we also released new material on sepsis, such as updated infographics, as well as translated our existing sepsis awareness material to more languages. ## **How our activities deliver public benefit** Our main activities and who we try to help are described below. All our charitable activities focus on raising awareness and understanding of sepsis and its treatment and this remains our key challenge. All our activities are undertaken to further our charitable purposes for the public benefit. Despite advances in modern medicine, including vaccines, antibiotics, and intensive care, sepsis remains the primary cause of death from infection, including viral infections such as COVID-19. Sepsis, which is often misunderstood by the public as "blood-poisoning" is one of the leading causes of death around the world. Sepsis arises when the body's response to an infection injures its own tissues and organs. It may lead to shock, multiple organ failure, and death, especially if not recognized early and treated promptly. Between one third and one half of patients with sepsis die. In the developing world, sepsis accounts for 60-80% of lost lives per year in childhood, killing more than 6 million neonates and children yearly and is responsible for more than 100,000 cases of maternal sepsis. Every hour, over 1,000 people die from sepsis. We have a simple message: sepsis must receive utmost priority as a medical emergency, so that all patients can expect to receive basic interventions, including antibiotics and intravenous fluids, within the first hour. ## **What examples exist of who has benefited?** In 2012, the Ropy Staunton Foundation and Global Sepsis Alliance announced that they will unite to fight against sepsis, claims 17 deaths per minute, 24,480 deaths every day and 8-9 million lives annually. Our collaboration has continued into 2021 to create global sepsis awareness and mandates. 12-year-old Ropy scratched his elbow playing school basketball on March 29th, 2012. He soon became unwell and, having previously been sent home from a leading New York hospital, died four days later from unrecognized sepsis. We formed a Communications Committee under the leadership of Dr Ron Daniels. This Committee was formed to recognize that public awareness is created through action and communication. The Committee will help to further develop ideas and our communications strategy to the press and social media over the whole year and especially around World Sepsis Day. Our efforts on social media are going well, with double-digit growth on Twitter, Facebook, and Instagram. Page 3 Global Sepsis Alliance ## Report of the Trustees ## for the Year Ended 31 December 2022 The GSA also has a Quality Improvement Committee (QIC), focusing on research and quality improvement. That includes better protocols in hospitals to detect sepsis earlier, when it is easier to treat and manage. ## **PLANS FOR FUTURE PERIODS** The charity plans continuing the activities outlined above in the forthcoming years subject to satisfactory funding arrangements. We plan to host another the 4th World Sepsis Congress in April 2023, as well as the 2024 WSC Spotlight in 2024. All other projects, for example WSD and the GSA Awards, will be continued in 2022. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Governing document** The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006. The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006. The organization is a charitable company limited by guarantee, incorporated on December 22nd, 2010 and registered as a charity on June 8th, 2011. The company was established under a Memorandum of Association which established the objects and powers of the charitable company and is governed under its Articles of Association. In the event of the company being wound up members are required to contribute an amount not exceeding £1.00 GBP. ## **Recruitment and appointment of new trustees** The Directors of the company are also charity trustees for the purposes of charity law and under the company's Articles are known as the Trustees. The day-to-day management of the company is the responsibility of the members of the Executive Committee who are elected to serve for a period of three years after which they must be re-elected at the next Annual General Meeting. All members of the Executive Committee give their time voluntarily and received no benefits from the charity. ## **Induction and training of new trustees** The Trustees are already familiar with the practical work of the charity. A formal induction and training program will be considered as and when new Trustees are appointed. This training will include: - The obligations of Executive Board members. - The main documents which set out the operational framework for the charity including the Memorandum and Articles. - Resourcing and the current financial position as set out in the latest published accounts. - Future plans and objectives. ## **Risk management** The Trustees have conducted a review of the major risks to which the charity is exposed. The charity is still in its formative years and therefore the risk assessment has been confined to an assessment of financial outlook and the ability of the charity to fund its current and future activities. The charity has three current employees and no property or significant investments. However, the need for the charity to conduct a more comprehensive risk assessment (for example to include the completion of a Risk Register and Health and Safety Review) will be conducted annually and a further determination made. ## **REFERENCE AND ADMINISTRATIVE DETAILS** ## **Registered Company number** 07476120 (England and Wales) ## **Registered Charity number** 1142803 Page 4 Global Sepsis Alliance Report of the Trustees for the Year Ended 31 December 2022 ## **Registered office** 12 Park Lane Tilehurst Reading Berkshire RG31 5DL ## **Trustees** Mr. Philip Taylor Director Dr. Konrad Anton Reinhart Director Dr. Darren Ron Daniels Director ## **Company Secretary** Mr. Philip Taylor ## **Independent Examiner** Avalon Accounting Limited 12 Park Lane Tilehurst Reading Berkshire RG31 5DL ## **Solicitors** Russell-Cooke LLP 2 Putney Hill London SW15 6AB ## **Bankers** Barclays Bank plc Commerzbank Aldermaston Road Fischergasse 10 Tadley 07743 Basingstoke Jena Hampshire Germany RG26 4QA ## **Executive Committee** Abdulelah Alhawsawi Brett Abbenbroek Daniela Souza Dennis Kredler Emmanuel Nsutebu Imrana Malik Maha Aljuaid Niranjan 'Tex' Kissoon Ron Daniels Shevin Jacob ## **Board Members** Abdulelah Alhawsawi, Alison Fox-Robichaud, Antonio Artigas, Brett Abbenbroek, Daniela Souza, Dennis Kredler, Emmanuel Nsutebu, Evangelos Giamarellos-Bourboulis, Halima Salisu Kabara, Imrana Malik, Louise Thwaites, Luis Antonio Gorordo Del Sol, Maha Aljuaid, Mitchell Levy, Naoyuki Matsuda, Niranjan 'Tex' Kissoon, Ron Daniels, Shevin Jacob, Tobias Welte, Ulrika Knutsson Page 5 Global Sepsis Alliance ## Report of the Trustees for the Year Ended 31 December 2022 Approved by order of the board of trustees on ............................................. and signed on its behalf by: ................................................................................ Mr. Philip Taylor - Trustee Page 6 Independent Examiner's Report to the Trustees of Global Sepsis Alliance ## **Independent examiner's report to the trustees of Global Sepsis Alliance ('the Company')** I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2022. ## **Responsibilities and basis of report** As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act. ## **Independent examiner's statement** Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)). I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Sanjay Swarup Avalon Accounting Limited 12 Park Lane Tilehurst Reading Berkshire RG31 5DL Date: ............................................. Page 7 ## Global Sepsis Alliance ## Statement of Financial Activities ## for the Year Ended 31 December 2022 |2022
Unrestricted
fund
Notes
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
2
198,833
Other trading activities
3
55,277
**Total**
254,110
**EXPENDITURE ON**
Raising funds
4
373,060
**NET INCOME/(EXPENDITURE)**
(118,950)
**RECONCILIATION OF FUNDS**
Total funds brought forward
749,485
**TOTAL FUNDS CARRIED FORWARD**
630,535|2021
Total
funds
£
211,550
131,553| |---|---| ||343,103| ||209,276| ||133,827
615,658| ||749,485| The notes form part of these financial statements Page 8 Global Sepsis Alliance ## Balance Sheet 31 December 2022 |2022
Unrestricted
fund
Notes
£
**FIXED ASSETS**
Tangible assets
9
10,162
**CURRENT ASSETS**
Debtors
10
79,706
Cash at bank
548,561
628,267
**CREDITORS**
Amounts falling due within one year
11
(7,894)
**NET CURRENT ASSETS**
620,373
**TOTAL ASSETS LESS CURRENT LIABILITIES**
630,535
**NET ASSETS**
630,535
**FUNDS**
12
Unrestricted funds
630,535
**TOTAL FUNDS**
630,535|2021
Total
funds
£
8,858
89,936
655,593
745,529
(4,902)
740,627
749,485
749,485
749,485
749,485| |---|---| The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2022. The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2022 in accordance with Section 476 of the Companies Act 2006. The trustees acknowledge their responsibilities for - (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and - (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. The notes form part of these financial statements continued... Page 9 Global Sepsis Alliance ## Balance Sheet - continued 31 December 2022 These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: ............................................. Mr. Philip Taylor - Trustee The notes form part of these financial statements Page 10 Global Sepsis Alliance ## Notes to the Financial Statements for the Year Ended 31 December 2022 ## **1. ACCOUNTING POLICIES** ## **BASIS OF PREPARING THE FINANCIAL STATEMENTS** The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. ## **INCOME** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ## **EXPENDITURE** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. ## **TANGIBLE FIXED ASSETS** Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. Plant and machinery - 25% on reducing balance Fixtures and fittings - 25% on reducing balance Computer equipment - 25% on reducing balance ## **TAXATION** The charity is exempt from corporation tax on its charitable activities. ## **FUND ACCOUNTING** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. ## **2. DONATIONS AND LEGACIES** ||2022|2021| |---|---|---| ||£|£| |Donations|198,833|211,550| continued... Page 11 Global Sepsis Alliance ## Notes to the Financial Statements - continued for the Year Ended 31 December 2022 ## **3. OTHER TRADING ACTIVITIES** |**3.**|**OTHER TRADING ACTIVITIES**||||| |---|---|---|---|---|---| |||||2022|2021| |||||£|£| ||Sponsorships|||55,277|131,553| |**4.**|**RAISING FUNDS**||||| ||**RAISING DONATIONS AND LEGACIES**||||| |||||2022|2021| |||||£|£| ||Postage and stationery|||1,841|2,747| ||Other direct cost|||3,646|16,953| ||Travel subsistence & accommodation|||3,179|2,434| ||Event costs|||96,594|55,479| ||Support costs|||267,800|131,663| |||||373,060|209,276| |**5.**|**SUPPORT COSTS**||||| ||||||Information| ||||Management|Finance|technology| ||||£|£|£| ||Raising donations and legacies||231,495|448|5,806| |||||Governance|| |||Other|Other 2|costs|Totals| |||£|£|£|£| ||Raising donations and legacies|3,388|2,223|24,440|267,800| |**6.**|**NET INCOME/(EXPENDITURE)**||||| ||Net income/(expenditure) is stated after charging/(crediting):||||| |||||2022|2021| |||||£|£| ||Depreciation - owned assets|||3,388|7,136| Depreciation - owned assets continued... Page 12 Global Sepsis Alliance ## Notes to the Financial Statements - continued for the Year Ended 31 December 2022 ## **7. TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the year ended 31 December 2022 nor for the year ended 31 December 2021. ## **TRUSTEES' EXPENSES** There were no trustees' expenses paid for the year ended 31 December 2022 nor for the year ended 31 December 2021. ## **8. STAFF COSTS** |**STAFF COSTS**||| |---|---|---| |Wages and salaries|2022
£
168,656
168,656|2021
£
125,747| |||125,747| The average monthly number of employees during the year was as follows: ||2022|2021| |---|---|---| |Employees|8|8| No employees received emoluments in excess of £60,000. ## **9. TANGIBLE FIXED ASSETS** |Fixtures
Plant and
and
Computer
machinery
fittings
equipment
£
£
£
**COST**
At 1 January 2022
838
8,172
15,105
Additions
-
-
4,692
At 31 December 2022
838
8,172
19,797
**DEPRECIATION**
At 1 January 2022
419
5,091
9,747
Charge for year
105
770
2,513
At 31 December 2022
524
5,861
12,260
**NET BOOK VALUE**
At 31 December 2022
314
2,311
7,537
At 31 December 2021
419
3,081
5,358|Totals
£
24,115
4,692| |---|---| ||28,807| ||15,257
3,388| ||18,645| ||10,162| ||8,858| continued... Page 13 Global Sepsis Alliance ## Notes to the Financial Statements - continued for the Year Ended 31 December 2022 |**10.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Trade debtors
Investment
VAT
**11.**
**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Social security and other taxes
Accrued expenses
**12.**
**MOVEMENT IN FUNDS**
**Unrestricted funds**
General fund
**TOTAL FUNDS**
Net movement in funds, included in the above are as follows:
**Unrestricted funds**
General fund
**TOTAL FUNDS**|2022
2021
£
£
60,398
70,836
18,639
18,639
669
461
79,706
89,936
2022
2021
£
£
6,209
3,342
1,685
1,560
7,894
4,902
Net
movement
At
At 1.1.22
in funds
31.12.22
£
£
£
749,485
(118,950)
630,535
749,485
(118,950)
630,535
Incoming
Resources
Movement
resources
expended
in funds
£
£
£
254,110
(373,060)
(118,950)
254,110
(373,060)
(118,950)| |---|---| continued... Page 14 Global Sepsis Alliance ## Notes to the Financial Statements - continued for the Year Ended 31 December 2022 ## **12. MOVEMENT IN FUNDS - continued** ## **Comparatives for movement in funds** ||Net|| |---|---|---| ||movement|At| |At 1.1.21|in funds|31.12.21| |£|£|£| |**Unrestricted funds**||| |General fund
615,658|133,827|749,485| |**TOTAL FUNDS**
615,658|133,827|749,485| |Comparative net movement in funds, included in the above are as follows:||| |Incoming|Resources|Movement| |resources|expended|in funds| |£|£|£| |**Unrestricted funds**||| |General fund
343,103|(209,276)|133,827| |**TOTAL FUNDS**
343,103|(209,276)|133,827| |A current year 12 months and prior year 12 months combined position is as follows:||| ||Net|| ||movement|At| |At 1.1.21|in funds|31.12.22| |£|£|£| |**Unrestricted funds**||| |General fund
615,658|14,877|630,535| |**TOTAL FUNDS**
615,658|14,877|630,535| A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: |**Unrestricted funds**
General fund
**TOTAL FUNDS**|Incoming
resources
£
597,213
597,213|Resources
Movement
expended
in funds
£
£
(582,336)
14,877
(582,336)
14,877|Resources
Movement
expended
in funds
£
£
(582,336)
14,877
(582,336)
14,877| |---|---|---|---| ||||14,877| Page 15 continued... Global Sepsis Alliance Notes to the Financial Statements - continued for the Year Ended 31 December 2022 ## **13. RELATED PARTY DISCLOSURES** Insights in Healthcare Ltd provided secretariat services to Global Sepsis Alliance during the year totalling £3,000 (PY - £2,525). Mr. Philip Taylor is common director in both company. Page 16 ## Global Sepsis Alliance |**INCOME AND ENDOWMENTS**
**Donations and legacies**
Donations
**Other trading activities**
Sponsorships
**Total incoming resources**
**EXPENDITURE**
**Raising donations and legacies**
Postage and stationery
Other direct cost
Travel subsistence & accommodation
Event costs
**Support costs**
**Management**
Wages
Computer Cost
Insurance
Office Rent
Staff welfare
Telephone
Advertising
Office cost
Bookkeeping
Consultancy
Foreign Exchange Loss
**Finance**
Bank charges
Paypal charges
**Information technology**
Website development|Detailed Statement of Financial Activities
for the Year Ended 31 December 2022|2022
£
198,833
55,277
254,110
1,841
3,646
3,179
96,594
105,260
168,656
5,785
39,276
9,987
79
859
5,146
266
768
2,000
(1,327)
231,495
336
112
448
5,806|2021
£
211,550
131,553
343,103
2,747
16,953
2,434
55,479
77,613
125,747
(4,790)
(40,162)
6,585
322
852
6,885
158
918
2,345
7,157
106,017
366
207
573
4,566| |---|---|---|---| ||||| This page does not form part of the statutory financial statements Page 17 ## Global Sepsis Alliance |**Information technology**
**Other**
Plant and machinery
Fixtures and fittings
Computer equipment
**Other 2**
Subscription
**Governance costs**
Membership fees
Accountancy fees
Secretary
Total resources expended
**Net (expenditure)/income**|Detailed Statement of Financial Activities
for the Year Ended 31 December 2022|2022
£
105
770
2,513
3,388
2,223
19,755
1,685
3,000
24,440
373,060
(118,950)|2021
£
139
1,027
5,970| |---|---|---|---| ||||| ||||7,136
689
8,597
1,560
2,525| ||||12,682| ||||209,276| ||||133,827| This page does not form part of the statutory financial statements Page 18